CNS Pharmacology USMLE Step 1 Practice Question
A 64-year-old man presents with acute anterior wall myocardial infarction (troponin I 4.2 ng/mL). He undergoes coronary stent placement and is started on aspirin. Vital signs: BP 118/76, HR 92, RR 16, Temp 37°C, SpO2 98%. He is prescribed a second antiplatelet agent that irreversibly inhibits the P2Y12 receptor and blocks ADP-induced platelet aggregation. He denies any prior bleeding disorders. Which medication was most likely added to his dual antiplatelet therapy regimen?
Answer choices
- AHeparin
- BClopidogrelCorrect answer
- CAlteplase
- DEptifibatide
- EAbciximab
- FTicagrelor
See the full explanation
Get the correct-answer rationale, why each distractor is wrong, the underlying mechanism, and high-yield associations — plus adaptive practice that targets your weak areas — with a free MedBoardPRO account.